• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    LeMaitre Vascular, Inc. - Common Stock (NQ:LMAT)

    112.57 -2.24 (-1.95%)
    Streaming Delayed Price Updated: 1:23 PM EDT, Apr 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about LeMaitre Vascular, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    News headline image
    LMAT Q3 Deep Dive: Pricing and Margin Expansion Offset by Cautious Growth Outlook
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 11.4% year on year to $61.05 million. Next quarter’s revenue guidance of... 
    Via StockStory
    News headline image
    LeMaitre (NASDAQ:LMAT) Reports Sales Below Analyst Estimates In Q3 Earnings
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) fell short of the markets revenue expectations in Q3 CY2025, but sales rose 11.4% year on year to $61.05 million. Next quarter’s revenue guidance... 
    Via StockStory
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
     
    Via Benzinga
    News headline image
    LeMaitre Earnings: What To Look For From LMAT
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be reporting results this Thursday after the bell. Here’s what investors should know. 
    Via StockStory
    News headline image
    Earnings Scheduled For August 5, 2025 ↗
     
    Via Benzinga
    News headline image
    3 Cash-Producing Stocks We Think Twice About
    While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
    Via StockStory
    News headline image
    Where LeMaitre Vascular Stands With Analysts ↗
     
    Via Benzinga
    News headline image
    3 of Wall Street’s Favorite Stocks We Think Twice About
    Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
    Via StockStory
    News headline image
    Surgical Equipment & Consumables - Specialty Stocks Q2 Earnings Review: LeMaitre (NASDAQ:LMAT) Shines
    As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including LeMaitre (NASDAQ:LMAT) and its peers. 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    1 High-Flying Stock with Solid Fundamentals and 2 We Ignore
    Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly... 
    Via StockStory
    News headline image
    Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement
    New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a... 
    Via MarketMinute
    Topics Government
    News headline image
    Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
    Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing... 
    Via MarketMinute
    Topics Economy Government World Trade
    News headline image
    AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know
    A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
    Via StockStory
    Topics Government
    News headline image
    3 Reasons LMAT is Risky and 1 Stock to Buy Instead
    Since March 2025, LeMaitre has been in a holding pattern, posting a small return of 1.8% while floating around $85.45. The stock also fell short of the S&P 500’s 18.6% gain during that period. 
    Via StockStory
    Topics Stocks Supply Chain
    News headline image
    Integra LifeSciences and LeMaitre Shares Are Falling, What You Need To Know
    A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
    Via StockStory
    Topics World Trade
    News headline image
    1 Profitable Stock with Solid Fundamentals and 2 We Ignore
    Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
    Via StockStory
    News headline image
    LeMaitre Vascular Inc. (NASDAQ:LMAT) Exemplifies Quality Investing Principles in Caviar Cruise Screen ↗
    LeMaitre Vascular (LMAT) exemplifies quality investing with strong revenue growth, a 32.83% ROIC, and robust cash flow. A top pick from the Caviar Cruise screen for durable, high-quality stocks. 
    Via Chartmill
    News headline image
    Astrana Health, Privia Health, Illumina, Waters Corporation, and LeMaitre Shares Plummet, What You Need To Know
    A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
    Via StockStory
    Topics Economy
    News headline image
    Why LeMaitre (LMAT) Stock Is Down Today
    Shares of medical device company LeMaitre Vascular (NASDAQ:LMAT) fell 2.2% in the afternoon session after the stock traded lower amid broader market weakness. U.S. stock markets began September trading... 
    Via StockStory
    Topics Bonds Stocks World Trade
    News headline image
    LMAT Q2 Deep Dive: International Expansion and Product Momentum Drive Upbeat Outlook
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 15% year on year to $64.23 million. Guidance for next... 
    Via StockStory
    News headline image
    Why LeMaitre (LMAT) Stock Is Trading Up Today
    Shares of medical device company LeMaitre Vascular (NASDAQ:LMAT) jumped 9.5% in the afternoon session after the company reported better-than-expected second-quarter financial results and raised its... 
    Via StockStory
    Topics ETFs Stocks World Trade
    News headline image
    LeMaitre (LMAT) Q2 Revenue Jumps 15% ↗
    Via The Motley Fool
    News headline image
    LeMaitre (NASDAQ:LMAT) Exceeds Q2 Expectations, Full-Year Sales Guidance is Optimistic
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 15% year on year to $64.23 million. Guidance for next quarter’s... 
    Via StockStory
    News headline image
    LeMaitre (LMAT) Reports Q2: Everything You Need To Know Ahead Of Earnings
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be reporting results this Tuesday after market close. Here’s what to expect. 
    Via StockStory
    Topics Artificial Intelligence World Trade
    News headline image
    LEMAITRE VASCULAR INC (NASDAQ:LMAT) – A Quality Stock Worth Considering ↗
    LEMAITRE VASCULAR INC (NASDAQ:LMAT) shows strong growth, high profitability, and solid financial health, making it a candidate for quality investors. The stock meets key criteria with a 31.7% ROIC and... 
    Via Chartmill
    News headline image
    Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know
    A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned... 
    Via StockStory
    Topics ETFs Stocks World Trade
    News headline image
    Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
    New Directors Bring Extensive NASDAQ Expertise Across Legal, Operational and Corporate Leadership Capacities 
    From Anteris Technologies Global Corp.
    Via GlobeNewswire
    News headline image
    Intuitive Surgical (NASDAQ:ISRG): Strongest Q1 Results from the Surgical Equipment & Consumables - Specialty Group
    The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Intuitive Surgical... 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    LMAT Q1 Earnings Call: Sales Growth Outpaces Expectations, Margin Pressures Addressed
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 12% year on year to $59.87 million. The company expects next quarter’s revenue... 
    Via StockStory
    Topics World Trade
    News headline image
    1 Cash-Heavy Stock That Stand Out and 2 to Question
    A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
    Via StockStory
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.